Skip to main content
Caplight Logo









Altis Biosystems

Altis Biosystems

Private
Durham, North CarolinaHealthcare & Life Scienceshttps://www.altisbiosystems.com/

Last Round

Grant

Jul 1, 2023

Total Funding Raised

$4.69M

Company Overview

Altis Biosystems is a biotechnology company that provides a stem cell technology platform, RepliGut®, which recreates the human intestinal epithelium for use in preclinical drug discovery, compound screening, and microbiome research.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting, Hardware Sales

AI Layer

Non-AI

Keywords

organ-on-a-chippreclinical drug discoveryintestinal tissue modelshigh-throughput screeningcontract research organizationCROin vitro testingtoxicity testingdrug efficacyhuman stem cellsmicrophysiological systemsMPSanimal model alternativesgastrointestinal researchtissue engineering

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Altis Biosystems Comparables

Compare Altis Biosystems with similar companies based on industry and business-model similarity.

Altis Biosystems comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Emulate
85%
Dynamic42
85%
MIMETAS
85%

Altis Biosystems Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJul 1, 2023
DebtFeb 16, 2022
GrantFeb 2, 2021
SeedAug 11, 2020
GrantApr 25, 2019
Grant
Nov 20, 2017

Key People

Founding team and executive leadership

Ben Scruggs

Chairman & CEO

Executive Team

Altis Biosystems Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 2, 2021

    $75K grant received from One North Carolina Small Business Program.

  • Apr 25, 2019

    $50K grant from One North Carolina Small Business Program.

Altis Biosystems Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Altis Biosystems Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Altis Biosystems's valuation, stock price, and market status.

Firmographic Details

HeadquartersDurham, North Carolina
Employee Range29
Year Founded2015
Last FundingJul 1, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?